维普中文期刊产品整合服务
73篇 您的检索式:作者名="Spigel R"
    题名 作者 年代 出处 被引量
1Treatment of metastatic renal cell carcinoma with a combination of bevacizu-nab and erlotinib显示文摘Hainsworth J D Sosman J A Spigel D R 2005J Clin Oncol2005,23,31:1
2Phase II trial of bevacizumab and everolimus in patients with advanced renal cell carcinoma显示文摘Hainsworth J D Spigel D R Burris H R 2010J Clin Oncol2010,28,13:1
3First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations显示文摘Sequist L V Martins R G Spigel D 2008J Clin Oncol2008,26,15:1
4Phase Ⅰ/Ⅱ trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction显示文摘Spigel D R Greco F A Meluch A A 2010J Clin Oncol2010,28,13:1
5Rationale for chemotherapy,immunother- apy,and checkpoint blockade in SCLC:beyond traditional treatment approaches显示文摘Spigel D R Soeinski M A 2013J Thorac Oncol2013,8,5:1
6Final efficacy resuhs from OAM4558g, a randomized phase II study evaluating MetMAb or placebo in combination with erlotinib in advanced NSCLC显示文摘Spigel DR Ervin TJ Ramlau R 2011J Clin Oncol2011,,:1
7Chemotherapy in metastatic and locally advanced non-small cell lung cancer显示文摘SPIGEL D R GRECO F A 2003Semin Surg Oncol2003,21,2:1
8Rituximab with short duration chemotherapy followed by ^90Y- Ibritumomab tiuxetana as first - line treatment for patients with follicular lymphoma: update of a Minnie Pearl Cancer Research Network phase II trial显示文摘Shipley D Greco F Spigel R 2005J Clin Oncol2005,23,16:1
9Weekly docetaxel versus docetaxel/gemcitabine in elderly/poor performance status (PS) patients (pts) with stage ⅢB/Ⅳ non-small cell lung cancer (NSCLC):Randomized phase Ⅲ trial of the minnie pearl cancer research network显示文摘GRECO F A SPIGEL D R BURRIS H A 2007J Clin Oncol2007,,:1
10Treatment of metastatic renal cell carcinoma with a combination of bevacizumab and Erlotinib显示文摘Hainsworth J D Sosman J A Spigel D R 2005J Clin Oncol2005,23,31:1
11Phase II study of maintenance sunitinih following irinoteean and earboplatin as first -line treatment for patients with ex- tensive- stage small- cell lung cancer 显示文摘Spigel D R Greeo F A Rubin M S 2012Lung Cancer2012,77,2:1
12Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer 显示文摘Spigel D R Greco F A Zubkus J D 2009J Thorac Oncol2009,4,12:1
13Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial显示文摘Spigel D R Townley P M Waterhouse D M 2011J Clin Oncol2011,29,16:1
14First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations 显示文摘SEQUIST L V MARTINS R G SPIGEL D 2008J Clin Oncol2008,26,15:1
15First-line ge- fitinib in patients with advanced non- small- cell lung cancer harboring somatic EGFR mutations显示文摘SEQUIST L V MARTINS R G SPIGEL D 2008J Clin Oncol2008,26,15:1
16Phase II trial of bevacizumab and erlotinib in carcinomas of un- known primary site: the Minnie Pearl Cancer Research Network显示文摘Hainsworth J D Spigel D R Farley C 2007J Clin Oncol2007,25,13:1
17Hydrodynamic implications of large offshore mussel farms显示文摘Plew D R Stevens C L Spigel R H 2005IEEE Journal of Oceanic Engineering2005,30,1:1
18Phase II trial of bevacizumab and everolimus in patients with advanced renal cell carcinoma显示文摘Hainsworth J D Spigel D R Burris H A 3rd 2010J Clin Oncol2010,28,13:1
19Final efficacy results from OAM4558g, a randomized phase II study evaluating MetMAb or pla- cebo in combination with erlotinib in advanced NSCLC 显示文摘Spigel D R Ervin T J Ramlau R 2011J Clin Oncol2011,,:1
20Randomized phase Ill trial of amrubicin versus topotecan (Topo) as second- line treatment for small cell lung cancer (SCLC)显示文摘Jotte R Von Pawel J Spigel D R 2011J Clin Oncol2011,29,15:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费